VolitionRx issues shares to Lind Global under convertible note conversions
VolitionRx converted portions of its senior secured convertible notes into common stock across seven transactions dated August 27 and August 31, 2026.
VolitionRx Limited disclosed in an 8-K filing that it issued multiple tranches of common stock to Lind Global Asset Management XII LLC to satisfy conversion obligations under existing convertible promissory notes. The notes stem from a securities purchase agreement dated May 15, 2025, later amended and restated on January 7, 2026, under which VolitionRx had issued Lind senior secured convertible promissory notes with original principal amounts of $7,500,000 and $2,400,000.1
On August 27, 2026, the company issued 712,328 shares to cover a $260,000 conversion obligation, followed by a second issuance that day of 520,547 shares tied to a $190,000 obligation. on August 27, 2026 the Company issued to Lind an aggregate of 712,328 shares of common stock to satisfy a $260,000 conversion obligation, (b) on August 27, 2026 the Company issued to Lind an aggregate of 520,547 shares of common stock to satisfy a $190,000 conversion obligation1
Five additional issuances occurred on August 31, 2026. on August 31, 2026 the Company issued to Lind an aggregate of 698,630 shares of common stock to satisfy a $255,000 conversion obligation, (d) on August 31, 2026 the Company issued to Lind an aggregate of 695,890 shares of common stock to satisfy a $254,000 conversion obligation, (e) on August 31, 2026 the Company issued to Lind an aggregate of 693,151 shares of common stock to satisfy a $253,000 conversion obligation, (f) on August 31, 2026 the Company issued to Lind an aggregate of 690,411 shares of common stock to satisfy a $252,000 conversion obligation, and (g) on August 31, 2026 the Company issued to Lind an aggregate of 687,671 shares of common stock to satisfy a $251,000 conversion obligation.1
The filing states the offerings relied on an exemption under what it describes as "Section 3(a)(9) or alternatively Section 4(a)(2) of the Securities Act of 1933," and/or Rule 506 of Regulation D under the Securities Act, and corresponding provisions of state securities or blue sky laws.1 The issuance of the shares of common stock was to an existing securityholder, did not involve any paid commissions, did not involve a public offering and was made without general solicitation or general advertising.1
The 8-K was signed by Cameron Reynolds, Chief Executive Officer and President, and dated September 1, 2026.
Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.